pubmed-article:2488020 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:2488020 | lifeskim:mentions | umls-concept:C0035309 | lld:lifeskim |
pubmed-article:2488020 | lifeskim:mentions | umls-concept:C0008269 | lld:lifeskim |
pubmed-article:2488020 | lifeskim:mentions | umls-concept:C0031061 | lld:lifeskim |
pubmed-article:2488020 | lifeskim:mentions | umls-concept:C1511790 | lld:lifeskim |
pubmed-article:2488020 | lifeskim:mentions | umls-concept:C1522609 | lld:lifeskim |
pubmed-article:2488020 | lifeskim:mentions | umls-concept:C1554112 | lld:lifeskim |
pubmed-article:2488020 | pubmed:issue | 1-2 | lld:pubmed |
pubmed-article:2488020 | pubmed:dateCreated | 1991-4-18 | lld:pubmed |
pubmed-article:2488020 | pubmed:abstractText | Various forms of perimetry are used to confirm Chloroquine retinopathy diagnosed by Amsler grid testing. Little is known about the value of using a red target generated statically. The purpose of this study was to determine the sensitivity and specificity of both red and white perimetry using program 10-2 on the Humphrey automated perimeter. Sixty-nine eyes were tested in total. Fifty eyes were from patients with known early Chloroquine retinopathy with abnormal Amslers. Red perimetry was 91.3% sensitive and 57.8% specific for Chloroquine retinopathy. White perimetry was 78% sensitive and 84% specific for this condition. In conclusion, red Humphrey perimetry was highly sensitive but not highly specific for Chloroquine retinopathy. | lld:pubmed |
pubmed-article:2488020 | pubmed:language | eng | lld:pubmed |
pubmed-article:2488020 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2488020 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:2488020 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2488020 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:2488020 | pubmed:issn | 1042-6922 | lld:pubmed |
pubmed-article:2488020 | pubmed:author | pubmed-author:EasterbrookMM | lld:pubmed |
pubmed-article:2488020 | pubmed:author | pubmed-author:TropeGG | lld:pubmed |
pubmed-article:2488020 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:2488020 | pubmed:volume | 6 | lld:pubmed |
pubmed-article:2488020 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:2488020 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:2488020 | pubmed:pagination | 255-68 | lld:pubmed |
pubmed-article:2488020 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
pubmed-article:2488020 | pubmed:meshHeading | pubmed-meshheading:2488020-... | lld:pubmed |
pubmed-article:2488020 | pubmed:meshHeading | pubmed-meshheading:2488020-... | lld:pubmed |
pubmed-article:2488020 | pubmed:meshHeading | pubmed-meshheading:2488020-... | lld:pubmed |
pubmed-article:2488020 | pubmed:meshHeading | pubmed-meshheading:2488020-... | lld:pubmed |
pubmed-article:2488020 | pubmed:meshHeading | pubmed-meshheading:2488020-... | lld:pubmed |
pubmed-article:2488020 | pubmed:meshHeading | pubmed-meshheading:2488020-... | lld:pubmed |
pubmed-article:2488020 | pubmed:meshHeading | pubmed-meshheading:2488020-... | lld:pubmed |
pubmed-article:2488020 | pubmed:meshHeading | pubmed-meshheading:2488020-... | lld:pubmed |
pubmed-article:2488020 | pubmed:meshHeading | pubmed-meshheading:2488020-... | lld:pubmed |
pubmed-article:2488020 | pubmed:year | 1989 | lld:pubmed |
pubmed-article:2488020 | pubmed:articleTitle | Value of Humphrey perimetry in the detection of early chloroquine retinopathy. | lld:pubmed |
pubmed-article:2488020 | pubmed:affiliation | Department of Ophthalmology, University of Toronto, Ontario. | lld:pubmed |
pubmed-article:2488020 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:2488020 | pubmed:publicationType | Case Reports | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2488020 | lld:pubmed |